16 research outputs found

    In situ assessment of the timber structure of an 18th century building in Madrid, Spain

    No full text
    The timber structural members of a seven-story building from the end of the 18th century were evaluated following a procedure based on previous research works. The structure consisted of timber-framed brick walls and heavy timber floors with mortar filling. Non-destructive measurements were taken in 13 sampling areas of the floors and framed walls. Detailed measurements of at least 3 pieces in each sample were taken (stress wave Time-of-Flight and probing tests). Mean density and modulus of elasticity values and characteristic values of bending and compression strength were estimated. On-site load tests were carried out on three floor slabs to deduce their actual bending stiffness and compare it with estimation by NDT. They behaved more rigidly than expected, which is explained by floor screed stiffness, the transverse stiffness effect and possible semi-rigid connection behaviour at the supports. Structural verification determined the required strength of the critical members to compare this with the estimated strengths, showing a correct safety level

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text

    Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

    No full text

    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

    No full text
    10.1161/CIRCULATIONAHA.119.042551CIRCULATION140191578-158
    corecore